Industry Reports

Ionis Pharmaceuticals and Akcea Therapeutics, Inc., an affiliate of Ionis, announced an exclusive, worldwide license by Ionis to Akcea for inotersen and AKCEA-TTR-LRx, formerly…
Read More...

H. Lundbeck A/S (Lundbeck) and Prexton Therapeutics BV (Prexton) announced signing of a definitive agreement in which Lundbeck will acquire Prexton. Under terms of the agreement,…
Read More...

Mallinckrodt plc announced it has closed the sale of RECOTHROM Thrombin topical (Recombinant) and PREVELEAK Surgical Sealant to Baxter International Inc. "This action further…
Read More...

Ardelyx, Inc. announced a license agreement with Knight Therapeutics, Inc. (Knight) that provides Knight with exclusive rights to commercialize tenapanor in Canada. Tenapanor is…
Read More...

Nexcelom Bioscience announced that it has received a strategic investment from Ampersand Capital Partners. The funding will be primarily used to support Nexcelom's worldwide growth…
Read More...

Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients, announced today $16…
Read More...

Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle) product platform, announced the promotion of…
Read More...

X-Chem, Inc. announced the appointment of Christelle Huguet, Ph.D. as Chief Scientific Officer, along with an executive leadership appointment for Matthew Clark, Ph.D. as Senior Vice…
Read More...

Dr. Reddy’s Laboratories Ltd announced that it has launched Levocetirizine Dihydrochloride Tablets USP, 5 mg, an over-the-counter therapeutic equivalent generic version of Xyzal Allergy…
Read More...

Ionis Pharmaceuticals and Akcea Therapeutics announced an exclusive, worldwide license by Ionis to Akcea for inotersen and AKCEA-TTR-LRx, formerly IONIS-TTR-LRx, in a transaction…
Read More...

Illumina asserted the appointment of Dr. Phil Febbo who is a Leading physician scientist, as Chief Medical Officer (CMO), starting March 26, 2018. In his new role, Dr. Febbo will be…
Read More...

The American Society for Radiation Oncology declared a new clinical guideline for the usage of whole breast radiation therapy for breast Cancer augmenting the population of patients…
Read More...

When compared to medical therapies, a bariatric surgeon and an endocrinologist specializing in diabetes observed that the effectiveness of medical versus surgical intervention proved to…
Read More...

Intec Pharma asserted that it has partnered with LTS Lohmann Therapie-Systeme AG for manufacturing Company's lead candidate, Accordion Pill Carbidopa/Levodopa (AP-CD/LD) as a treatment…
Read More...

Malachite Management asserted that it has recently been granted accreditation by Association Management Company Institute (AMCI), the global trade association representing the…
Read More...

Royal Philips which is a global leader in health technology claimed health economic results from DEFINE FLAIR clinical trial comparing cost-effectiveness between instant wave-free ratio…
Read More...

Tango Therapeutics which is a biotechnology company creating novel, targeted medicines for specific cancer subtypes claimed the addition of three experienced leaders with deep…
Read More...

Eyenuk which is a leading developer of advanced artificial intelligence enabled clinically supported solutions to identify diseases via retinal image analysis declared that it has…
Read More...

TherapeuticsMD which is an innovative women's healthcare company claimed the FDA's admission of NDA for TX-001HR. TX-001HR is the company’s investigational bio-identical hormone therapy…
Read More...

InVivo Therapeutics Holdings Corporation became recipient of supplemental Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) for a second…
Read More...